US Patent Issued to The Wistar Institute of Anatomy and Biology on May 13 for "Use of lactoferrin for generating myeloid-derived suppressor cells" (Pennsylvania Inventor)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,990, issued on May 13, was assigned to The Wistar Institute of Anatomy and Biology (Philadelphia).

"Use of lactoferrin for generating myeloid-derived suppressor cells" was invented by Dmitry I. Gabrilovich (Villanova, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of generating MDSCs ex vivo. The methods include culturing blood cells with lactoferrin."

The patent was filed on Aug. 13, 2019, under Application No. 17/291,808.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l...